Novo Nordisk cuts Wegovy prices, following similar move for Zepbound by Eli Lilly
Novo Nordisk’s new offering follows a direct-to-consumer model that Eli Lilly launched last year.
Health Care & Insurance
Articles
Startup Emboa Medical’s device mimics boa constrictor’s teeth to remove blood clots
The pre-clinical West Lafayette-based medical device startup is working to develop a new “microstructred” catheter to remove blood clots that cause strokes.
Lilly cuts undisclosed number of jobs, ‘nothing large scale’
The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new manufacturing facilities at four yet-to-be-named U.S. locations.
IU Health reports higher annual revenue as patient numbers rise
IU Health said inpatient and outpatient surgeries returned to levels last year not seen since before the COVID-19 pandemic.
Study co-authored by IU researcher finds generic drugs made in India have more severe adverse events
The results showed that the number of severe adverse events for patients was 54.3% higher than that of drugs made in emerging economies.
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Supplies of high-demand obesity treatments are improving, but that doesn’t mean they’re easier to get.
Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.
Roughly 16 million people—that’s 6 percent of American adults—are taking GLP-1 weight-loss drugs, and that number is growing rapidly. Their collective purchasing power has the potential to profoundly reshape the economy.
Nonprofit hospitals targeted for high prices in bill passing the House
The bill allows the state to revoke the nonprofit status of a health system or hospital that charges especially high fees.
U.S. reverses plan to shut down free COVID test program
Internal documents show that officials at HHS had been considering whether to continue the program or dispose of millions of tests.
Advocates warn of wide-ranging impact of proposed HIP changes
Senate Bill 2 would introduce restrictions on the Healthy Indiana Plan, a Medicaid program that pays for the health care needs of more than 750,000 Hoosiers.
Lebanon planning board to review designs for Lilly’s $4.5B foundry at LEAP District
IMAGE GALLERY: The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, scientists, operations personnel and lab technicians.
How NIH research funding works, and why universities are worried
At the heart of the debate over support for scientific research is a not-widely-known element of the federal grant process known as the “facilities and administrative,” or indirect costs.
Amended bill would hit nonprofit hospitals with excise tax over high prices
A new amendment to House Bill 1004 would create an excise tax that would penalize hospitals found to be over-charging patients.
Devoted nap-takers find benefits to sleeping on the job
Multiple studies have extolled the benefits of napping, such as enhanced memory and focus.
Employers increasingly promote wellbeing to workers
Beyond the usual cholesterol checks and annual physicals, workplace wellness now encompasses all sorts of programs and services for the mind, body and spirit.
FDA approves non-opioid painkiller Journavx
The painkiller is the first novel pain drug to win government authorization in more than 20 years.
OrthoIndy promotes Lavery to president
Dr. Matthew Lavery has been promoted to president at the Indianapolis-based orthopedic practice, succeeding the retiring Dr. Edward Hellman.
Opponents say bill would punish, financially harm Indiana’s nonprofit hospitals
House Bill 1004 would strip hospitals of their nonprofit status if they exceed certain price thresholds.
Purdue Pharma and owners to pay $7.4B in settlement over OxyContin’s toll
The deal represents an increase of more than $1 billion over a previous settlement deal that was rejected last year by the U.S. Supreme Court.
UPDATE: Elevance Health shares tick up on better-than-expected earnings
The company also reported higher medical expenses, mainly from its Medicaid business.